Pentra

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamePentra
Drug Alias Nameantibodies (Delenex)therapeutic antibody fragments (Delenex Therapeutics)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment
Mechanisms of ActionCNS modulators
TargetsUpdating
Therapy Area/IndicationsCentral Nervous System DiseasesLung Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCell Medica Switzerland AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCell Medica Switzerland AG
Active IndicationsN/A
Inactive IndicationsCentral Nervous System DiseasesLung Diseases

Other Information

ATC CodeN/A
Related LinksN/A